Jason Fontenot
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jason Fontenot
The proxy statement of Sangamo Therapeutics, Inc reports total compensation of $972,242 for Jason Fontenot in fiscal 2023, including a base salary of $512,179. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Sangamo Therapeutics, Inc (SGMOQ)
Proxy statement
Start not stated–2023-04-17
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Sangamo Therapeutics, Inc (SGMOQ) | Former Senior Vice President, Chief Scientific Officer | $512,179 | $972,242 |
| 2022 | Sangamo Therapeutics, Inc (SGMOQ) | Former Senior Vice President, Chief Scientific Officer | $474,240 | $1,414,648 |
Recent activity
No call appearances or filed executive changes recorded yet.